These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21964795)

  • 1. Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients.
    Torrecilla E; Fernández-Vázquez G; Vicent D; Sánchez-Franco F; Barabash A; Cabrerizo L; Sánchez-Pernaute A; Torres AJ; Rubio MA
    Obes Surg; 2012 Mar; 22(3):478-86. PubMed ID: 21964795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
    Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
    Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of omental 11β-HSD1 is not increased in severely obese women with metabolic syndrome.
    Michalaki M; Kyriazopoulou V; Antonacopoulou A; Koika V; Nikolaou M; Tsoukas A; Kalfarentzos F; Vagenakis AG; Voukelatou G; Papavassiliou AG
    Obes Facts; 2012; 5(1):104-11. PubMed ID: 22433622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
    Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
    Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling.
    Simonyte K; Rask E; Näslund I; Angelhed JE; Lönn L; Olsson T; Mattsson C
    Obesity (Silver Spring); 2009 Nov; 17(11):1982-7. PubMed ID: 19360009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
    Ahmed A; Rabbitt E; Brady T; Brown C; Guest P; Bujalska IJ; Doig C; Newsome PN; Hubscher S; Elias E; Adams DH; Tomlinson JW; Stewart PM
    PLoS One; 2012; 7(2):e29531. PubMed ID: 22363403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
    Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
    Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
    Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue.
    Simonyte K; Olsson T; Näslund I; Angelhed JE; Lönn L; Mattsson C; Rask E
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3527-31. PubMed ID: 20410231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects.
    Li S; Tao T; Wang L; Mao X; Zheng J; Zhao A; Liu W
    Horm Metab Res; 2013 Oct; 45(11):802-7. PubMed ID: 23979790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1.
    Fan Z; Du H; Zhang M; Meng Z; Chen L; Liu Y
    Mol Cell Endocrinol; 2011 Feb; 333(1):62-9. PubMed ID: 21163329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.